Status:

COMPLETED

Network-Level Mechanisms for Preclinical Alzheimer's Disease Development

Lead Sponsor:

Medical College of Wisconsin

Collaborating Sponsors:

National Institute on Aging (NIA)

Conditions:

APOE 4

Eligibility:

All Genders

55-75 years

Phase:

PHASE2

Brief Summary

The purpose of this project is to test the hypothesis that AGB101 low dose levetiracetam extended release formulation can reduce abnormal hyperfunctional activity in the hippocampus in normal, healthy...

Detailed Description

In this study the investigators want to find out whether the use of a perturbation, such as AGB101 low dose of levetiracetam extended release formulation, in healthy adults can reduce abnormal hippoca...

Eligibility Criteria

Inclusion

  • Fluent in English
  • At least eight (8) years of education
  • Geriatric Depression Scale (GDS) (62) score \< 6
  • Hachinski Ischemic Score ≤ 4
  • Normal general cognitive function as well as 1) normal memory function, documented by MOCA score of 23 or greater, and a RBANS Delayed Memory Index score of 85 or greater.

Exclusion

  • Neurological disease, such as Parkinson's disease, multi-infarct dementia, Huntington's disease, normal pressure hydrocephalus, brain tumor, progressive supranuclear palsy, seizure disorder, subdural hematoma, multiple sclerosis, or a history of significant head trauma or known structural brain abnormalities
  • Major psychiatric disease or chronic unstable medical conditions
  • History of drug abuse
  • History of alcohol abuse (4 or greater drinks per day on average)
  • Unable to complete MRI scans (no Pacemaker/Defibrillator)
  • Known clinically significant abnormalities in B12 or thyroid function tests
  • End Stage Renal Disease (ESRD)
  • Hemodialysis (HD)

Key Trial Info

Start Date :

April 11 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 31 2021

Estimated Enrollment :

26 Patients enrolled

Trial Details

Trial ID

NCT03461861

Start Date

April 11 2019

End Date

March 31 2021

Last Update

July 3 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Froedtert & The Medical College of Wisconsin

Milwaukee, Wisconsin, United States, 53226